><title>References</title><ref id="b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maxwell</surname><given-names>JC</given-names></name></person-group><article-title>Review of &#x0201c;A treatise in the kinetic theory of gases&#x0201d; by Henry William Watson</article-title><source>Nature</source><year>1877</year><volume>18</volume><fpage>242</fpage><lpage>246</lpage></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name></person-group><article-title>Mycobacterium tuberculosis and the intimate discourse of a chronic infection</article-title><source>Immunol Rev</source><year>2011</year><volume>240</volume><fpage>252</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">21349098</pub-id></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrews</surname><given-names>JR</given-names></name><name><surname>Noubary</surname><given-names>F</given-names></name><name><surname>Walensky</surname><given-names>RP</given-names></name><name><surname>Cerda</surname><given-names>R</given-names></name><name><surname>Losina</surname><given-names>E</given-names></name><name><surname>Horsburgh</surname><given-names>CR</given-names></name></person-group><article-title>Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis</article-title><source>Clin Infect Dis</source><year>2012</year><volume>54</volume><fpage>784</fpage><lpage>791</lpage><pub-id pub-id-type="pmid">22267721</pub-id></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Muhsen</surname><given-names>S</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name></person-group><article-title>The genetic heterogeneity of mendelian susceptibility to mycobacterial diseases</article-title><source>J Allergy Clin Immunol</source><year>2008</year><volume>122</volume><fpage>1043</fpage><lpage>1051</lpage><comment>quiz 1052&#x02013;1043</comment><pub-id pub-id-type="pmid">19084105</pub-id></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Beaucoudrey</surname><given-names>L</given-names></name><etal/></person-group><article-title>Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries</article-title><source>Medicine (Baltimore)</source><year>2010</year><volume>89</volume><fpage>381</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">21057261</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sologuren</surname><given-names>I</given-names></name><etal/></person-group><article-title>Partial recessive IFN-gammaR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds</article-title><source>Hum Mol Genet</source><year>2011</year><volume>20</volume><fpage>1509</fpage><lpage>1523</lpage><pub-id pub-id-type="pmid">21266457</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Browne</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Adult-onset immunodeficiency in Thailand and Taiwan</article-title><source>N Engl J Med</source><year>2012</year><volume>367</volume><fpage>725</fpage><lpage>734</lpage><pub-id pub-id-type="pmid">22913682</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name></person-group><article-title>Immunology of tuberculosis</article-title><source>Annu Rev Immunol</source><year>2001</year><volume>19</volume><fpage>93</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">11244032</pub-id></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><name><surname>Chan</surname><given-names>J</given-names></name><name><surname>Triebold</surname><given-names>KJ</given-names></name><name><surname>Dalton</surname><given-names>DK</given-names></name><name><surname>Stewart</surname><given-names>TA</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name></person-group><article-title>An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection</article-title><source>J Exp Med</source><year>1993</year><volume>178</volume><fpage>2249</fpage><lpage>2254</lpage><pub-id pub-id-type="pmid">7504064</pub-id></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Dalton</surname><given-names>DK</given-names></name><name><surname>Stewart</surname><given-names>TA</given-names></name><name><surname>Griffin</surname><given-names>JP</given-names></name><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group><article-title>Disseminated tuberculosis in interferon gamma gene-disrupted mice</article-title><source>J Exp Med</source><year>1993</year><volume>178</volume><fpage>2243</fpage><lpage>2247</lpage><pub-id pub-id-type="pmid">8245795</pub-id></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="other"><collab>WHO/UNAIDS</collab><year>2011</year><comment>Global HIV/AIDS Response. Epidemic Update and Health Sector Progress Towards Universal Access. Progress report</comment></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geldmacher</surname><given-names>C</given-names></name><etal/></person-group><article-title>Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection</article-title><source>J Infect Dis</source><year>2008</year><volume>198</volume><fpage>1590</fpage><lpage>1598</lpage><pub-id pub-id-type="pmid">19000013</pub-id></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dixon</surname><given-names>WG</given-names></name><etal/></person-group><article-title>Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register</article-title><source>Arthritis Rheum</source><year>2006</year><volume>54</volume><fpage>2368</fpage><lpage>2376</lpage><pub-id pub-id-type="pmid">16868999</pub-id></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koike</surname><given-names>T</given-names></name><etal/></person-group><article-title>Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients</article-title><source>Ann Rheum Dis</source><year>2011</year><volume>70</volume><fpage>2148</fpage><lpage>2151</lpage><pub-id pub-id-type="pmid">21852254</pub-id></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flynn</surname><given-names>JL</given-names></name><etal/></person-group><article-title>Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice</article-title><source>Immunity</source><year>1995</year><volume>2</volume><fpage>561</fpage><lpage>572</lpage><pub-id pub-id-type="pmid">7540941</pub-id></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez-Juarrero</surname><given-names>M</given-names></name><etal/></person-group><article-title>Disruption of granulocyte macrophage-colony stimulating factor production in the lungs severely affects the ability of mice to control Mycobacterium tuberculosis infection</article-title><source>J Leukoc Biol</source><year>2005</year><volume>77</volume><fpage>914</fpage><lpage>922</lpage><pub-id pub-id-type="pmid">15767289</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo</article-title><source>J Immunol</source><year>2010</year><volume>184</volume><fpage>3326</fpage><lpage>3330</lpage><pub-id pub-id-type="pmid">20200276</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname><given-names>BM</given-names></name><name><surname>Briscoe</surname><given-names>H</given-names></name><name><surname>Britton</surname><given-names>WJ</given-names></name></person-group><article-title>T cell-derived tumour necrosis factor is essential, but not sufficient, for protection against Mycobacterium tuberculosis infection</article-title><source>Clin Exp Immunol</source><year>2004</year><volume>137</volume><fpage>279</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">15270844</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Woodworth</surname><given-names>JS</given-names></name></person-group><article-title>Tuberculosis vaccines&#x02013;rethinking the current paradigm</article-title><source>Trends Immunol</source><year>2014</year><volume>35</volume><fpage>387</fpage><lpage>395</lpage><pub-id pub-id-type="pmid">24875637</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittrucker</surname><given-names>HW</given-names></name><etal/></person-group><article-title>Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>12434</fpage><lpage>12439</lpage><pub-id pub-id-type="pmid">17640915</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldsack</surname><given-names>L</given-names></name><name><surname>Kirman</surname><given-names>JR</given-names></name></person-group><article-title>Half-truths and selective memory: interferon gamma, CD4(+) T cells and protective memory against tuberculosis</article-title><source>Tuberculosis</source><year>2007</year><volume>87</volume><fpage>465</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">17719276</pub-id></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kagina</surname><given-names>BM</given-names></name><etal/></person-group><article-title>Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guerin vaccination of newborns</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><fpage>1073</fpage><lpage>1079</lpage><pub-id pub-id-type="pmid">20558627</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tameris</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial</article-title><source>Lancet</source><year>2013</year><volume>381</volume><fpage>1021</fpage><lpage>1028</lpage><pub-id pub-id-type="pmid">23391465</pub-id></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diel</surname><given-names>R</given-names></name><name><surname>Loddenkemper</surname><given-names>R</given-names></name><name><surname>Meywald-Walter</surname><given-names>K</given-names></name><name><surname>Niemann</surname><given-names>S</given-names></name><name><surname>Nienhaus</surname><given-names>A</given-names></name></person-group><article-title>Predictive value of a whole blood IFN-gamma assay for the development of active tuberculosis disease after recent infection with Mycobacterium tuberculosis</article-title><source>Am J Respir Crit Care Med</source><year>2008</year><volume>177</volume><fpage>1164</fpage><lpage>1170</lpage><pub-id pub-id-type="pmid">18276940</pub-id></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doherty</surname><given-names>TM</given-names></name><etal/></person-group><article-title>Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients</article-title><source>J Clin Microbiol</source><year>2002</year><volume>40</volume><fpage>704</fpage><lpage>706</lpage><pub-id pub-id-type="pmid">11826002</pub-id></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higuchi</surname><given-names>K</given-names></name><name><surname>Harada</surname><given-names>N</given-names></name><name><surname>Fukazawa</surname><given-names>K</given-names></name><name><surname>Mori</surname><given-names>T</given-names></name></person-group><article-title>Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis</article-title><source>Tuberculosis</source><year>2008</year><volume>88</volume><fpage>244</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">18294915</pub-id></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skerry</surname><given-names>C</given-names></name><name><surname>Harper</surname><given-names>J</given-names></name><name><surname>Klunk</surname><given-names>M</given-names></name><name><surname>Bishai</surname><given-names>WR</given-names></name><name><surname>Jain</surname><given-names>SK</given-names></name></person-group><article-title>Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e39680</fpage><pub-id pub-id-type="pmid">22761866</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subbian</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs</article-title><source>PLoS Pathog</source><year>2011</year><volume>7</volume><fpage>e1002262</fpage><pub-id pub-id-type="pmid">21949656</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casadevall</surname><given-names>A</given-names></name><name><surname>Pirofski</surname><given-names>LA</given-names></name></person-group><article-title>The damage-response framework of microbial pathogenesis</article-title><source>Nat Rev Microbiol</source><year>2003</year><volume>1</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">15040176</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>DS</given-names></name><name><surname>Soares</surname><given-names>MP</given-names></name></person-group><article-title>Disease tolerance as a defense strategy</article-title><source>Science</source><year>2012</year><volume>335</volume><fpage>936</fpage><lpage>941</lpage><pub-id pub-id-type="pmid">22363001</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nunes-Alves</surname><given-names>C</given-names></name><name><surname>Booty</surname><given-names>MG</given-names></name><name><surname>Carpenter</surname><given-names>SM</given-names></name><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Rothchild</surname><given-names>AC</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>In search of a new paradigm for protective immunity to TB</article-title><source>Nat Rev Microbiol</source><year>2014</year><volume>12</volume><fpage>289</fpage><lpage>299</lpage><pub-id pub-id-type="pmid">24590243</pub-id></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name><etal/></person-group><article-title>The spectrum of latent tuberculosis: rethinking the biology and intervention strategies</article-title><source>Nat Rev Microbiol</source><year>2009</year><volume>7</volume><fpage>845</fpage><lpage>855</lpage><pub-id pub-id-type="pmid">19855401</pub-id></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Radiologic responses in cynomolgous macaques for assessing tuberculosis chemotherapy regimens</article-title><source>Antimicrob Agents Chemother</source><year>2013</year><volume>57</volume><fpage>4237</fpage><lpage>4244</lpage></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>PL</given-names></name><etal/></person-group><article-title>Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing</article-title><source>Nat Med</source><year>2014</year><volume>20</volume><fpage>75</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">24336248</pub-id></element-citation></ref><ref id="b35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DG</given-names></name><name><surname>Barry</surname><given-names>CE</given-names><suffix>3rd</suffix></name><name><surname>Flynn</surname><given-names>JL</given-names></name></person-group><article-title>Tuberculosis: what we don't know can, and does, hurt us</article-title><source>Science</source><year>2010</year><volume>328</volume><fpage>852</fpage><lpage>856</lpage><pub-id pub-id-type="pmid">20466922</pub-id></element-citation></ref><ref id="b36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>MP</given-names></name><etal/></person-group><article-title>An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis</article-title><source>Nature</source><year>2010</year><volume>466</volume><fpage>973</fpage><lpage>977</lpage><pub-id pub-id-type="pmid">20725040</pub-id></element-citation></ref><ref id="b37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><etal/></person-group><article-title>Transcriptional blood signatures distinguish pulmonary tuberculosis, pulmonary sarcoidosis, pneumonias and lung cancers</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e70630</fpage><pub-id pub-id-type="pmid">23940611</pub-id></element-citation></ref><ref id="b38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lesho</surname><given-names>E</given-names></name><etal/></person-group><article-title>Transcriptional responses of host peripheral blood cells to tuberculosis infection</article-title><source>Tuberculosis</source><year>2011</year><volume>91</volume><fpage>390</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">21835698</pub-id></element-citation></ref><ref id="b39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>C</given-names></name><etal/></person-group><article-title>Novel biomarkers distinguishing active tuberculosis from latent infection identified by gene expression profile of peripheral blood mononuclear cells</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e24290</fpage><pub-id pub-id-type="pmid">21904626</pub-id></element-citation></ref><ref id="b40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><etal/></person-group><article-title>Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e26938</fpage><pub-id pub-id-type="pmid">22046420</pub-id></element-citation></ref><ref id="b41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maertzdorf</surname><given-names>J</given-names></name><etal/></person-group><article-title>Common patterns and disease-related signatures in tuberculosis and sarcoidosis</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>7853</fpage><lpage>7858</lpage><pub-id pub-id-type="pmid">22547807</pub-id></element-citation></ref><ref id="b42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>CI</given-names></name><etal/></person-group><article-title>Detectable changes in the blood transcriptome are present after two weeks of antituberculosis therapy</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e46191</fpage><pub-id pub-id-type="pmid">23056259</pub-id></element-citation></ref><ref id="b43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dorhoi</surname><given-names>A</given-names></name><etal/></person-group><article-title>Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics</article-title><source>Eur J Immunol</source><year>2014</year><volume>44</volume><fpage>2380</fpage><lpage>2393</lpage><pub-id pub-id-type="pmid">24782112</pub-id></element-citation></ref><ref id="b44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayer-Barber</surname><given-names>KD</given-names></name><etal/></person-group><article-title>Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk</article-title><source>Nature</source><year>2014</year><volume>511</volume><fpage>99</fpage><lpage>103</lpage><pub-id pub-id-type="pmid">24990750</pub-id></element-citation></ref><ref id="b45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Redford</surname><given-names>PS</given-names></name><etal/></person-group><article-title>Influenza A virus impairs control of Mycobacterium tuberculosis coinfection through a type I interferon receptor-dependent pathway</article-title><source>J Infect Dis</source><year>2014</year><volume>209</volume><fpage>270</fpage><lpage>274</lpage><pub-id pub-id-type="pmid">23935205</pub-id></element-citation></ref><ref id="b46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNab</surname><given-names>FW</given-names></name><etal/></person-group><article-title>Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-gamma for production of IL-12 and bacterial killing in mycobacterium tuberculosis-infected macrophages</article-title><source>J Immunol</source><year>2014</year><volume>193</volume><fpage>3600</fpage><lpage>3612</lpage><pub-id pub-id-type="pmid">25187652</pub-id></element-citation></ref><ref id="b47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Byrnes</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy</article-title><source>J Leukoc Biol</source><year>2008</year><volume>84</volume><fpage>1447</fpage><lpage>1453</lpage><pub-id pub-id-type="pmid">18806124</pub-id></element-citation></ref><ref id="b48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hyrcza</surname><given-names>MD</given-names></name><etal/></person-group><article-title>Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells</article-title><source>J Virol</source><year>2007</year><volume>81</volume><fpage>3477</fpage><lpage>3486</lpage><pub-id pub-id-type="pmid">17251300</pub-id></element-citation></ref><ref id="b49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willis</surname><given-names>MD</given-names></name><name><surname>Winston</surname><given-names>CA</given-names></name><name><surname>Heilig</surname><given-names>CM</given-names></name><name><surname>Cain</surname><given-names>KP</given-names></name><name><surname>Walter</surname><given-names>ND</given-names></name><name><surname>Mac Kenzie</surname><given-names>WR</given-names></name></person-group><article-title>Seasonality of tuberculosis in the United States, 1993-2008</article-title><source>Clin Infect Dis</source><year>2012</year><volume>54</volume><fpage>1553</fpage><lpage>1560</lpage><pub-id pub-id-type="pmid">22474225</pub-id></element-citation></ref><ref id="b50"><label>50</label><element-citation publication-type="other"><person-group person-group-type="author"><name><surname>Evans</surname><given-names>TG</given-names></name></person-group><year>2014</year><comment>Update on TB vaccines-2014</comment></element-citation></ref><ref id="b51"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comas</surname><given-names>I</given-names></name><etal/></person-group><article-title>Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans</article-title><source>Nat Genet</source><year>2013</year><volume>45</volume><fpage>1176</fpage><lpage>1182</lpage><pub-id pub-id-type="pmid">23995134</pub-id></element-citation></ref><ref id="b52"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Comas</surname><given-names>I</given-names></name><etal/></person-group><article-title>Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved</article-title><source>Nat Genet</source><year>2010</year><volume>42</volume><fpage>498</fpage><lpage>503</lpage><pub-id pub-id-type="pmid">20495566</pub-id></element-citation></ref><ref id="b53"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Copin</surname><given-names>R</given-names></name><etal/></person-group><article-title>Sequence diversity in the pe_pgrs genes of Mycobacterium tuberculosis is independent of human T cell recognition</article-title><source>MBio</source><year>2014</year><volume>5</volume><fpage>e00960</fpage><lpage>00913</lpage><pub-id pub-id-type="pmid">24425732</pub-id></element-citation></ref><ref id="b54"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gagneux</surname><given-names>S</given-names></name></person-group><article-title>Host-pathogen coevolution in human tuberculosis</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2012</year><volume>367</volume><fpage>850</fpage><lpage>859</lpage><pub-id pub-id-type="pmid">22312052</pub-id></element-citation></ref><ref id="b55"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>CC</given-names></name><etal/></person-group><article-title>The effect of HIV-related immunosuppression on the risk of tuberculosis transmission to household contacts</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><fpage>765</fpage><lpage>774</lpage><pub-id pub-id-type="pmid">24368620</pub-id></element-citation></ref><ref id="b56"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>M</given-names></name><name><surname>Kasambira</surname><given-names>TS</given-names></name><name><surname>Adrian</surname><given-names>PV</given-names></name><name><surname>Madhi</surname><given-names>SA</given-names></name><name><surname>Martinson</surname><given-names>NA</given-names></name><name><surname>Dorman</surname><given-names>SE</given-names></name></person-group><article-title>Longitudinal analysis of QuantiFERON-TB Gold In-Tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study</article-title><source>PLoS ONE</source><year>2011</year><volume>6</volume><fpage>e26787</fpage><pub-id pub-id-type="pmid">22066009</pub-id></element-citation></ref><ref id="b57"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dharmadhikari</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Natural infection of guinea pigs exposed to patients with highly drug-resistant tuberculosis</article-title><source>Tuberculosis</source><year>2011</year><volume>91</volume><fpage>329</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">21478054</pub-id></element-citation></ref><ref id="b58"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barreto</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Evidence of an effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: second report of the BCG-REVAC cluster-randomised trial</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>4875</fpage><lpage>4877</lpage><pub-id pub-id-type="pmid">21616115</pub-id></element-citation></ref><ref id="b59"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>BasuRoy</surname><given-names>R</given-names></name><etal/></person-group><article-title>Identifying predictors of interferon-gamma release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study</article-title><source>Am J Respir Crit Care Med</source><year>2012</year><volume>186</volume><fpage>378</fpage><lpage>384</lpage><pub-id pub-id-type="pmid">22700862</pub-id></element-citation></ref><ref id="b60"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>PC</given-names></name><etal/></person-group><article-title>Lower prevalence of tuberculosis infection in BCG vaccinees: a cross-sectional study in adult prison inmates</article-title><source>Thorax</source><year>2013</year><volume>68</volume><fpage>263</fpage><lpage>268</lpage><pub-id pub-id-type="pmid">23019256</pub-id></element-citation></ref><ref id="b61"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eisenhut</surname><given-names>M</given-names></name><etal/></person-group><article-title>BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay</article-title><source>Vaccine</source><year>2009</year><volume>27</volume><fpage>6116</fpage><lpage>6120</lpage><pub-id pub-id-type="pmid">19715782</pub-id></element-citation></ref><ref id="b62"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roy</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of BCG vaccination against Mycobacterium tuberculosis infection in children: systematic review and meta-analysis</article-title><source>BMJ</source><year>2014</year><volume>349</volume><fpage>g4643</fpage><pub-id pub-id-type="pmid">25097193</pub-id></element-citation></ref><ref id="b63"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soysal</surname><given-names>A</given-names></name><etal/></person-group><article-title>Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study</article-title><source>Lancet</source><year>2005</year><volume>366</volume><fpage>1443</fpage><lpage>1451</lpage><pub-id pub-id-type="pmid">16243089</pub-id></element-citation></ref><ref id="b64"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>A</given-names></name></person-group><article-title>Some clinical features of tuberculosis. 1. Incubation period</article-title><source>Acta Tuberc Scand</source><year>1950</year><volume>24</volume><fpage>311</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">14783027</pub-id></element-citation></ref><ref id="b65"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wallgren</surname><given-names>A</given-names></name></person-group><article-title>The time-table of tuberculosis</article-title><source>Tubercle</source><year>1948</year><volume>29</volume><fpage>245</fpage><lpage>251</lpage><pub-id pub-id-type="pmid">18101320</pub-id></element-citation></ref><ref id="b66"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chackerian</surname><given-names>AA</given-names></name><name><surname>Alt</surname><given-names>JM</given-names></name><name><surname>Perera</surname><given-names>TV</given-names></name><name><surname>Dascher</surname><given-names>CC</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>4501</fpage><lpage>4509</lpage><pub-id pub-id-type="pmid">12117962</pub-id></element-citation></ref><ref id="b67"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reiley</surname><given-names>WW</given-names></name><etal/></person-group><article-title>ESAT-6-specific CD4 T cell responses to aerosol Mycobacterium tuberculosis infection are initiated in the mediastinal lymph nodes</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>10961</fpage><lpage>10966</lpage><pub-id pub-id-type="pmid">18667699</pub-id></element-citation></ref><ref id="b68"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wolf</surname><given-names>AJ</given-names></name><etal/></person-group><article-title>Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs</article-title><source>J Exp Med</source><year>2008</year><volume>205</volume><fpage>105</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">18158321</pub-id></element-citation></ref><ref id="b69"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khader</surname><given-names>SA</given-names></name><etal/></person-group><article-title>IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge</article-title><source>Nat Immunol</source><year>2007</year><volume>8</volume><fpage>369</fpage><lpage>377</lpage><pub-id pub-id-type="pmid">17351619</pub-id></element-citation></ref><ref id="b70"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Callahan</surname><given-names>JE</given-names></name><name><surname>Keen</surname><given-names>M</given-names></name><name><surname>Belisle</surname><given-names>JT</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group><article-title>Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis</article-title><source>Tuber Lung Dis</source><year>1997</year><volume>78</volume><fpage>67</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">9666964</pub-id></element-citation></ref><ref id="b71"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jung</surname><given-names>YJ</given-names></name><name><surname>Ryan</surname><given-names>L</given-names></name><name><surname>LaCourse</surname><given-names>R</given-names></name><name><surname>North</surname><given-names>RJ</given-names></name></person-group><article-title>Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice</article-title><source>J Exp Med</source><year>2005</year><volume>201</volume><fpage>1915</fpage><lpage>1924</lpage><pub-id pub-id-type="pmid">15955839</pub-id></element-citation></ref><ref id="b72"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karp</surname><given-names>CL</given-names></name></person-group><article-title>Unstressing intemperate models: how cold stress undermines mouse modeling</article-title><source>J Exp Med</source><year>2012</year><volume>209</volume><fpage>1069</fpage><lpage>1074</lpage><pub-id pub-id-type="pmid">22665703</pub-id></element-citation></ref><ref id="b73"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>PL</given-names></name><etal/></person-group><article-title>The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection</article-title><source>J Clin Invest</source><year>2012</year><volume>122</volume><fpage>303</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">22133873</pub-id></element-citation></ref><ref id="b74"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keele</surname><given-names>BF</given-names></name><etal/></person-group><article-title>Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection</article-title><source>Proc Natl Acad Sci USA</source><year>2008</year><volume>105</volume><fpage>7552</fpage><lpage>7557</lpage><pub-id pub-id-type="pmid">18490657</pub-id></element-citation></ref><ref id="b75"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname><given-names>CC</given-names></name><name><surname>O'Grady</surname><given-names>F</given-names></name><name><surname>Riley</surname><given-names>RL</given-names></name></person-group><article-title>Tuberculin conversion in the &#x0201c;naturally infected&#x0201d; guinea pig</article-title><source>Bull Johns Hopkins Hosp</source><year>1960</year><volume>106</volume><fpage>36</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">14422642</pub-id></element-citation></ref><ref id="b76"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riley</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Aerial dissemination of pulmonary tuberculosis. A two-year study of contagion in a tuberculosis ward. 1959</article-title><source>Am J Epidemiol</source><year>1995</year><volume>142</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">7785671</pub-id></element-citation></ref><ref id="b77"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abel</surname><given-names>L</given-names></name><name><surname>El-Baghdadi</surname><given-names>J</given-names></name><name><surname>Bousfiha</surname><given-names>AA</given-names></name><name><surname>Casanova</surname><given-names>JL</given-names></name><name><surname>Schurr</surname><given-names>E</given-names></name></person-group><article-title>Human genetics of tuberculosis: a long and winding road</article-title><source>Philos Trans R Soc Lond B Biol Sci</source><year>2014</year><volume>369</volume><fpage>20130428</fpage><pub-id pub-id-type="pmid">24821915</pub-id></element-citation></ref><ref id="b78"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cobat</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tuberculin skin test negativity is under tight genetic control of chromosomal region 11p14-15 in settings with different tuberculosis endemicities</article-title><source>J Infect Dis</source><year>2014</year><comment>;doi: <ext-link ext-link-type="doi" xlink:href="10.1093/infdis/jiu446">10.1093/infdis/jiu446</ext-link> (Online published)</comment></element-citation></ref><ref id="b79"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hawn</surname><given-names>TR</given-names></name><name><surname>Matheson</surname><given-names>AI</given-names></name><name><surname>Maley</surname><given-names>SN</given-names></name><name><surname>Vandal</surname><given-names>O</given-names></name></person-group><article-title>Host-directed therapeutics for tuberculosis: can we harness the host?</article-title><source>Microbiol Mol Biol Rev</source><year>2013</year><volume>77</volume><fpage>608</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">24296574</pub-id></element-citation></ref><ref id="b80"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spring</surname><given-names>M</given-names></name><name><surname>Polhemus</surname><given-names>M</given-names></name><name><surname>Ockenhouse</surname><given-names>C</given-names></name></person-group><article-title>Controlled human malaria infection</article-title><source>J Infect Dis</source><year>2014</year><volume>209</volume><issue>Suppl 2</issue><fpage>S40</fpage><lpage>S45</lpage><pub-id pub-id-type="pmid">24872394</pub-id></element-citation></ref><ref id="b81"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porter</surname><given-names>CK</given-names></name><etal/></person-group><article-title>A systematic review of experimental infections with enterotoxigenic Escherichia coli (ETEC)</article-title><source>Vaccine</source><year>2011</year><volume>29</volume><fpage>5869</fpage><lpage>5885</lpage><pub-id pub-id-type="pmid">21616116</pub-id></element-citation></ref><ref id="b82"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lyons</surname><given-names>AG</given-names></name></person-group><article-title>The human dengue challenge experience at the Walter Reed Army Institute of Research</article-title><source>J Infect Dis</source><year>2014</year><volume>209</volume><issue>Suppl 2</issue><fpage>S49</fpage><lpage>S55</lpage><pub-id pub-id-type="pmid">24872396</pub-id></element-citation></ref><ref id="b83"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seder</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine</article-title><source>Science</source><year>2013</year><volume>341</volume><fpage>1359</fpage><lpage>1365</lpage><pub-id pub-id-type="pmid">23929949</pub-id></element-citation></ref><ref id="b84"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minassian</surname><given-names>AM</given-names></name><name><surname>Satti</surname><given-names>I</given-names></name><name><surname>Poulton</surname><given-names>ID</given-names></name><name><surname>Meyer</surname><given-names>J</given-names></name><name><surname>Hill</surname><given-names>AV</given-names></name><name><surname>McShane</surname><given-names>H</given-names></name></person-group><article-title>A human challenge model for Mycobacterium tuberculosis using Mycobacterium bovis bacille Calmette-Guerin</article-title><source>J Infect Dis</source><year>2012</year><volume>205</volume><fpage>1035</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">22396610</pub-id></element-citation></ref><ref id="b85"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenthal</surname><given-names>SR</given-names></name><name><surname>McEnery</surname><given-names>JT</given-names></name><name><surname>Raisys</surname><given-names>N</given-names></name></person-group><article-title>Aerogenic BCG vaccination against tuberculosis in animal and human subjects</article-title><source>J Asthma Res</source><year>1968</year><volume>5</volume><fpage>309</fpage><lpage>323</lpage><pub-id pub-id-type="pmid">5666107</pub-id></element-citation></ref><ref id="b86"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JH</given-names></name><etal/></person-group><article-title>A genetic strategy to identify targets for the development of drugs that prevent bacterial persistence</article-title><source>Proc Natl Acad Sci USA</source><year>2013</year><volume>110</volume><fpage>19095</fpage><lpage>19100</lpage><pub-id pub-id-type="pmid">24191058</pub-id></element-citation></ref><ref id="b87"><label>87</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>BR</given-names></name><name><surname>Fine</surname><given-names>PEM</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bloom</surname><given-names>BR</given-names></name></person-group><article-title>The BCG experience: implications for future vaccines against tuberculosis</article-title><source>Tuberculosis: Pathogenesis, Protection, and Control</source><year>1994</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>531</fpage><lpage>557</lpage><comment>In: ed.</comment></element-citation></ref><ref id="b88"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered</article-title><source>J R Soc Interface</source><year>2013</year><volume>10</volume><fpage>20130365</fpage><pub-id pub-id-type="pmid">23904584</pub-id></element-citation></ref><ref id="b89"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trunz</surname><given-names>BB</given-names></name><name><surname>Fine</surname><given-names>P</given-names></name><name><surname>Dye</surname><given-names>C</given-names></name></person-group><article-title>Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness</article-title><source>Lancet</source><year>2006</year><volume>367</volume><fpage>1173</fpage><lpage>1180</lpage><pub-id pub-id-type="pmid">16616560</pub-id></element-citation></ref><ref id="b90"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colditz</surname><given-names>GA</given-names></name><etal/></person-group><article-title>Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature</article-title><source>JAMA</source><year>1994</year><volume>271</volume><fpage>698</fpage><lpage>702</lpage><pub-id pub-id-type="pmid">8309034</pub-id></element-citation></ref><ref id="b91"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mangtani</surname><given-names>P</given-names></name><etal/></person-group><article-title>Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><fpage>470</fpage><lpage>480</lpage><pub-id pub-id-type="pmid">24336911</pub-id></element-citation></ref><ref id="b92"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aronson</surname><given-names>NE</given-names></name><etal/></person-group><article-title>Long-term efficacy of BCG vaccine in American Indians and Alaska Natives: a 60-year follow-up study</article-title><source>JAMA</source><year>2004</year><volume>291</volume><fpage>2086</fpage><lpage>2091</lpage><pub-id pub-id-type="pmid">15126436</pub-id></element-citation></ref><ref id="b93"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodrigues</surname><given-names>LC</given-names></name><name><surname>Mangtani</surname><given-names>P</given-names></name><name><surname>Abubakar</surname><given-names>I</given-names></name></person-group><article-title>How does the level of BCG vaccine protection against tuberculosis fall over time?</article-title><source>BMJ</source><year>2011</year><volume>343</volume><fpage>d5974</fpage><pub-id pub-id-type="pmid">21964347</pub-id></element-citation></ref><ref id="b94"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behr</surname><given-names>MA</given-names></name><etal/></person-group><article-title>Comparative genomics of BCG vaccines by whole-genome DNA microarray</article-title><source>Science</source><year>1999</year><volume>284</volume><fpage>1520</fpage><lpage>1523</lpage><pub-id pub-id-type="pmid">10348738</pub-id></element-citation></ref><ref id="b95"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Favorov</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparative tuberculosis (TB) prevention effectiveness in children of Bacillus&#x000a0;Calmette-Guerin (BCG) vaccines from different sources, Kazakhstan</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e32567</fpage><pub-id pub-id-type="pmid">22427854</pub-id></element-citation></ref><ref id="b96"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tullius</surname><given-names>MV</given-names></name><name><surname>Harth</surname><given-names>G</given-names></name><name><surname>Maslesa-Galic</surname><given-names>S</given-names></name><name><surname>Dillon</surname><given-names>BJ</given-names></name><name><surname>Horwitz</surname><given-names>MA</given-names></name></person-group><article-title>A Replication-Limited Recombinant Mycobacterium bovis BCG vaccine against tuberculosis designed for human immunodeficiency virus-positive persons is safer and more efficacious than BCG</article-title><source>Infect Immun</source><year>2008</year><volume>76</volume><fpage>5200</fpage><lpage>5214</lpage><pub-id pub-id-type="pmid">18725418</pub-id></element-citation></ref><ref id="b97"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poyntz</surname><given-names>HC</given-names></name><name><surname>Stylianou</surname><given-names>E</given-names></name><name><surname>Griffiths</surname><given-names>KL</given-names></name><name><surname>Marsay</surname><given-names>L</given-names></name><name><surname>Checkley</surname><given-names>AM</given-names></name><name><surname>McShane</surname><given-names>H</given-names></name></person-group><article-title>Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis</article-title><source>Tuberculosis</source><year>2014</year><volume>94</volume><fpage>226</fpage><lpage>237</lpage><pub-id pub-id-type="pmid">24572168</pub-id></element-citation></ref><ref id="b98"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beverley</surname><given-names>PC</given-names></name><name><surname>Sridhar</surname><given-names>S</given-names></name><name><surname>Lalvani</surname><given-names>A</given-names></name><name><surname>Tchilian</surname><given-names>EZ</given-names></name></person-group><article-title>Harnessing local and systemic immunity for vaccines against tuberculosis</article-title><source>Mucosal Immunol</source><year>2014</year><volume>7</volume><fpage>20</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">24253104</pub-id></element-citation></ref><ref id="b99"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name></person-group><article-title>Future vaccination strategies against tuberculosis: thinking outside the box</article-title><source>Immunity</source><year>2010</year><volume>33</volume><fpage>567</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">21029966</pub-id></element-citation></ref><ref id="b100"><label>100</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Calmette</surname><given-names>A</given-names></name><name><surname>Guerin</surname><given-names>C</given-names></name><name><surname>Boquet</surname><given-names>A</given-names></name><name><surname>Negre</surname><given-names>L</given-names></name></person-group><source>La vaccination preventive contre la tuberculose par le &#x0201c;BCG&#x0201d;</source><year>1927</year><publisher-loc>Paris</publisher-loc><publisher-name>Masson</publisher-name></element-citation></ref><ref id="b101"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calmette</surname><given-names>A</given-names></name></person-group><article-title>Sur la vaccination preventive des enfants nouveau-nes contre la tuberculose par le BCG</article-title><source>Annales de l'Institute Pasteur</source><year>1927</year><volume>41</volume><fpage>201</fpage><lpage>232</lpage></element-citation></ref><ref id="b102"><label>102</label><element-citation publication-type="journal"><article-title>Meeting of the strategic advisory group of experts on immunization, April 2014 &#x02013; conclusions and recommendations</article-title><source>Wkly Epidemiol Rec</source><year>2014</year><volume>89</volume><fpage>221</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">24864348</pub-id></element-citation></ref><ref id="b103"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanden</surname><given-names>RV</given-names></name><name><surname>Lefford</surname><given-names>MJ</given-names></name><name><surname>Mackaness</surname><given-names>GB</given-names></name></person-group><article-title>The host response to Calmette-Guerin bacillus infection in mice</article-title><source>J Exp Med</source><year>1969</year><volume>129</volume><fpage>1079</fpage><lpage>1107</lpage><pub-id pub-id-type="pmid">4976109</pub-id></element-citation></ref><ref id="b104"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Werner</surname><given-names>GT</given-names></name></person-group><article-title>The effect of BCG-vaccination on vaccinia virus infections in mice</article-title><source>Experientia</source><year>1979</year><volume>35</volume><fpage>1514</fpage><lpage>1515</lpage><pub-id pub-id-type="pmid">389657</pub-id></element-citation></ref><ref id="b105"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ota</surname><given-names>MO</given-names></name><etal/></person-group><article-title>Influence of Mycobacterium bovis bacillus Calmette-Guerin on antibody and cytokine responses to human neonatal vaccination</article-title><source>J Immunol</source><year>2002</year><volume>168</volume><fpage>919</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">11777990</pub-id></element-citation></ref><ref id="b106"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandau</surname><given-names>S</given-names></name><name><surname>Suttmann</surname><given-names>H</given-names></name></person-group><article-title>Thirty years of BCG immunotherapy for non-muscle invasive bladder cancer: a success story with room for improvement</article-title><source>Biomed Pharmacother</source><year>2007</year><volume>61</volume><fpage>299</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">17604943</pub-id></element-citation></ref><ref id="b107"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Welsh</surname><given-names>RM</given-names></name><name><surname>Che</surname><given-names>JW</given-names></name><name><surname>Brehm</surname><given-names>MA</given-names></name><name><surname>Selin</surname><given-names>LK</given-names></name></person-group><article-title>Heterologous immunity between viruses</article-title><source>Immunol Rev</source><year>2010</year><volume>235</volume><fpage>244</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">20536568</pub-id></element-citation></ref><ref id="b108"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Netea</surname><given-names>MG</given-names></name><name><surname>Quintin</surname><given-names>J</given-names></name><name><surname>van der Meer</surname><given-names>JW</given-names></name></person-group><article-title>Trained immunity: a memory for innate host&#x000a0;defense</article-title><source>Cell Host Microbe</source><year>2011</year><volume>9</volume><fpage>355</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">21575907</pub-id></element-citation></ref><ref id="b109"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SC</given-names></name><etal/></person-group><article-title>mTOR- and HIF-1alpha-mediated aerobic glycolysis as metabolic basis for trained immunity</article-title><source>Science</source><year>2014</year><volume>345</volume><fpage>1250684</fpage><pub-id pub-id-type="pmid">25258083</pub-id></element-citation></ref><ref id="b110"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleinnijenhuis</surname><given-names>J</given-names></name><etal/></person-group><article-title>Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>17537</fpage><lpage>17542</lpage><pub-id pub-id-type="pmid">22988082</pub-id></element-citation></ref><ref id="b111"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>LF</given-names></name><name><surname>Kidd</surname><given-names>BA</given-names></name><name><surname>Han</surname><given-names>A</given-names></name><name><surname>Kotzin</surname><given-names>JJ</given-names></name><name><surname>Davis</surname><given-names>MM</given-names></name></person-group><article-title>Virus-specific CD4(+) memory-phenotype T cells are abundant in unexposed adults</article-title><source>Immunity</source><year>2013</year><volume>38</volume><fpage>373</fpage><lpage>383</lpage><pub-id pub-id-type="pmid">23395677</pub-id></element-citation></ref><ref id="b112"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Costa</surname><given-names>AC</given-names></name><name><surname>Nogueira</surname><given-names>SV</given-names></name><name><surname>Kipnis</surname><given-names>A</given-names></name><name><surname>Junqueira-Kipnis</surname><given-names>AP</given-names></name></person-group><article-title>Recombinant BCG: innovations on an old vaccine. Scope of BCG strains and strategies to improve long-lasting memory</article-title><source>Front Immunol</source><year>2014</year><volume>5</volume><fpage>152</fpage><pub-id pub-id-type="pmid">24778634</pub-id></element-citation></ref><ref id="b113"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaufmann</surname><given-names>SH</given-names></name><etal/></person-group><article-title>The BCG replacement vaccine VPM1002: from drawing board to clinical trial</article-title><source>Expert Rev Vaccines</source><year>2014</year><volume>13</volume><fpage>619</fpage><lpage>630</lpage><pub-id pub-id-type="pmid">24702486</pub-id></element-citation></ref><ref id="b114"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arbues</surname><given-names>A</given-names></name><etal/></person-group><article-title>Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials</article-title><source>Vaccine</source><year>2013</year><volume>31</volume><fpage>4867</fpage><lpage>4873</lpage><pub-id pub-id-type="pmid">23965219</pub-id></element-citation></ref><ref id="b115"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sacks</surname><given-names>DL</given-names></name></person-group><article-title>Vaccines against tropical parasitic diseases: a persisting answer to a persisting problem</article-title><source>Nat Immunol</source><year>2014</year><volume>15</volume><fpage>403</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">24747701</pub-id></element-citation></ref><ref id="b116"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Reyn</surname><given-names>CF</given-names></name><etal/></person-group><article-title>Prevention of tuberculosis in Bacille Calmette-Guerin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine</article-title><source>AIDS</source><year>2010</year><volume>24</volume><fpage>675</fpage><lpage>685</lpage><pub-id pub-id-type="pmid">20118767</pub-id></element-citation></ref><ref id="b117"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nell</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e89612</fpage><pub-id pub-id-type="pmid">24586912</pub-id></element-citation></ref><ref id="b118"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodgers</surname><given-names>JR</given-names></name><name><surname>Cook</surname><given-names>RG</given-names></name></person-group><article-title>MHC class Ib molecules bridge innate and acquired immunity</article-title><source>Nat Rev Immunol</source><year>2005</year><volume>5</volume><fpage>459</fpage><lpage>471</lpage><pub-id pub-id-type="pmid">15928678</pub-id></element-citation></ref><ref id="b119"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzel</surname><given-names>AS</given-names></name><etal/></person-group><article-title>HLA-E-dependent presentation of Mtb-derived antigen to human CD8+ T cells</article-title><source>J Exp Med</source><year>2002</year><volume>196</volume><fpage>1473</fpage><lpage>1481</lpage><pub-id pub-id-type="pmid">12461082</pub-id></element-citation></ref><ref id="b120"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joosten</surname><given-names>SA</given-names></name><etal/></person-group><article-title>Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity</article-title><source>PLoS Pathog</source><year>2010</year><volume>6</volume><fpage>e1000782</fpage><pub-id pub-id-type="pmid">20195504</pub-id></element-citation></ref><ref id="b121"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>GB</given-names></name><etal/></person-group><article-title>The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells</article-title><source>Immunity</source><year>1999</year><volume>10</volume><fpage>661</fpage><lpage>671</lpage><pub-id pub-id-type="pmid">10403641</pub-id></element-citation></ref><ref id="b122"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B</article-title><source>PLoS Pathog</source><year>2007</year><volume>3</volume><fpage>1240</fpage><lpage>1249</lpage><pub-id pub-id-type="pmid">17892322</pub-id></element-citation></ref><ref id="b123"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewinsohn</surname><given-names>DM</given-names></name><etal/></person-group><article-title>Classically restricted human CD8+ T lymphocytes derived from Mycobacterium tuberculosis-infected cells: definition of antigenic specificity</article-title><source>J Immunol</source><year>2001</year><volume>166</volume><fpage>439</fpage><lpage>446</lpage><pub-id pub-id-type="pmid">11123322</pub-id></element-citation></ref><ref id="b124"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindestam Arlehamn</surname><given-names>CS</given-names></name><name><surname>Lewinsohn</surname><given-names>D</given-names></name><name><surname>Sette</surname><given-names>A</given-names></name><name><surname>Lewinsohn</surname><given-names>D</given-names></name></person-group><article-title>Antigens for CD4 and CD8 T cells in tuberculosis</article-title><source>Cold Spring Harb Perspect Med</source><year>2014</year><volume>4</volume><fpage>a018465</fpage><pub-id pub-id-type="pmid">24852051</pub-id></element-citation></ref><ref id="b125"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geluk</surname><given-names>A</given-names></name><name><surname>van Meijgaarden</surname><given-names>KE</given-names></name><name><surname>Joosten</surname><given-names>SA</given-names></name><name><surname>Commandeur</surname><given-names>S</given-names></name><name><surname>Ottenhoff</surname><given-names>TH</given-names></name></person-group><article-title>Innovative strategies to identify M. tuberculosis antigens and epitopes using genome-wide analyses</article-title><source>Front Immunol</source><year>2014</year><volume>5</volume><fpage>256</fpage><pub-id pub-id-type="pmid">25009541</pub-id></element-citation></ref><ref id="b126"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoppes</surname><given-names>R</given-names></name><name><surname>Ekkebus</surname><given-names>R</given-names></name><name><surname>Schumacher</surname><given-names>TN</given-names></name><name><surname>Ovaa</surname><given-names>H</given-names></name></person-group><article-title>Technologies for MHC class I immunoproteomics</article-title><source>J Proteomics</source><year>2010</year><volume>73</volume><fpage>1945</fpage><lpage>1953</lpage><pub-id pub-id-type="pmid">20546957</pub-id></element-citation></ref><ref id="b127"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheridan</surname><given-names>BS</given-names></name><name><surname>Lefrancois</surname><given-names>L</given-names></name></person-group><article-title>Regional and mucosal memory T cells</article-title><source>Nat Immunol</source><year>2011</year><volume>12</volume><fpage>485</fpage><lpage>491</lpage><pub-id pub-id-type="pmid">21739671</pub-id></element-citation></ref><ref id="b128"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shane</surname><given-names>HL</given-names></name><name><surname>Klonowski</surname><given-names>KD</given-names></name></person-group><article-title>Every breath you take: the impact of environment on resident memory CD8 T cells in the lung</article-title><source>Front Immunol</source><year>2014</year><volume>5</volume><fpage>320</fpage><pub-id pub-id-type="pmid">25071780</pub-id></element-citation></ref><ref id="b129"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansen</surname><given-names>SG</given-names></name><etal/></person-group><article-title>Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine</article-title><source>Nature</source><year>2011</year><volume>473</volume><fpage>523</fpage><lpage>527</lpage><pub-id pub-id-type="pmid">21562493</pub-id></element-citation></ref><ref id="b130"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackay</surname><given-names>LK</given-names></name><etal/></person-group><article-title>Long-lived epithelial immunity by tissue-resident memory T (TRM) cells in the absence of persisting local antigen presentation</article-title><source>Proc Natl Acad Sci USA</source><year>2012</year><volume>109</volume><fpage>7037</fpage><lpage>7042</lpage><pub-id pub-id-type="pmid">22509047</pub-id></element-citation></ref><ref id="b131"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname><given-names>H</given-names></name><name><surname>Iwasaki</surname><given-names>A</given-names></name></person-group><article-title>A vaccine strategy that protects against genital herpes by establishing local memory T cells</article-title><source>Nature</source><year>2012</year><volume>491</volume><fpage>463</fpage><lpage>467</lpage><pub-id pub-id-type="pmid">23075848</pub-id></element-citation></ref><ref id="b132"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glatman-Freedman</surname><given-names>A</given-names></name><name><surname>Casadevall</surname><given-names>A</given-names></name></person-group><article-title>Serum therapy for tuberculosis revisited: reappraisal of the role of antibody-mediated immunity against Mycobacterium tuberculosis</article-title><source>Clin Microbiol Rev</source><year>1998</year><volume>11</volume><fpage>514</fpage><lpage>532</lpage><pub-id pub-id-type="pmid">9665981</pub-id></element-citation></ref><ref id="b133"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teitelbaum</surname><given-names>R</given-names></name><etal/></person-group><article-title>A mAb recognizing a surface antigen of Mycobacterium tuberculosis enhances host survival</article-title><source>Proc Natl Acad Sci USA</source><year>1998</year><volume>95</volume><fpage>15688</fpage><lpage>15693</lpage><pub-id pub-id-type="pmid">9861031</pub-id></element-citation></ref><ref id="b134"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinadayala</surname><given-names>P</given-names></name><name><surname>Sambou</surname><given-names>T</given-names></name><name><surname>Daffe</surname><given-names>M</given-names></name><name><surname>Lemassu</surname><given-names>A</given-names></name></person-group><article-title>Comparative structural analyses of the alpha-glucan and glycogen from Mycobacterium bovis</article-title><source>Glycobiology</source><year>2008</year><volume>18</volume><fpage>502</fpage><lpage>508</lpage><pub-id pub-id-type="pmid">18436565</pub-id></element-citation></ref><ref id="b135"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sani</surname><given-names>M</given-names></name><etal/></person-group><article-title>Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins</article-title><source>PLoS Pathog</source><year>2010</year><volume>6</volume><fpage>e1000794</fpage><pub-id pub-id-type="pmid">20221442</pub-id></element-citation></ref><ref id="b136"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Sinha</surname><given-names>T</given-names></name><name><surname>Carlson</surname><given-names>TK</given-names></name><name><surname>Keiser</surname><given-names>TL</given-names></name><name><surname>Torrelles</surname><given-names>JB</given-names></name><name><surname>Schlesinger</surname><given-names>LS</given-names></name></person-group><article-title>Changes in the major cell envelope components of Mycobacterium tuberculosis during in vitro growth</article-title><source>Glycobiology</source><year>2013</year><volume>23</volume><fpage>926</fpage><lpage>934</lpage><pub-id pub-id-type="pmid">23576535</pub-id></element-citation></ref><ref id="b137"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Born</surname><given-names>WK</given-names></name><name><surname>Reardon</surname><given-names>CL</given-names></name><name><surname>O'Brien</surname><given-names>RL</given-names></name></person-group><article-title>The function of gammadelta T cells in innate immunity</article-title><source>Curr Opin Immunol</source><year>2006</year><volume>18</volume><fpage>31</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">16337364</pub-id></element-citation></ref><ref id="b138"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Modlin</surname><given-names>RL</given-names></name><etal/></person-group><article-title>Lymphocytes bearing antigen-specific gamma delta T-cell receptors accumulate in human infectious disease lesions</article-title><source>Nature</source><year>1989</year><volume>339</volume><fpage>544</fpage><lpage>548</lpage><pub-id pub-id-type="pmid">2471938</pub-id></element-citation></ref><ref id="b139"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Lau</surname><given-names>YL</given-names></name><name><surname>Tu</surname><given-names>W</given-names></name></person-group><article-title>gammadelta-T cells: an unpolished sword in human anti-infection immunity</article-title><source>Cell Mol Immunol</source><year>2013</year><volume>10</volume><fpage>50</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">23064104</pub-id></element-citation></ref><ref id="b140"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hata</surname><given-names>S</given-names></name><etal/></person-group><article-title>Extensive junctional diversity of rearranged human T cell receptor delta genes</article-title><source>Science</source><year>1988</year><volume>240</volume><fpage>1541</fpage><lpage>1544</lpage><pub-id pub-id-type="pmid">3259726</pub-id></element-citation></ref><ref id="b141"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoft</surname><given-names>DF</given-names></name><name><surname>Brown</surname><given-names>RM</given-names></name><name><surname>Roodman</surname><given-names>ST</given-names></name></person-group><article-title>Bacille Calmette-Guerin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype</article-title><source>J Immunol</source><year>1998</year><volume>161</volume><fpage>1045</fpage><lpage>1054</lpage><pub-id pub-id-type="pmid">9670986</pub-id></element-citation></ref><ref id="b142"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lafaille</surname><given-names>JJ</given-names></name><name><surname>DeCloux</surname><given-names>A</given-names></name><name><surname>Bonneville</surname><given-names>M</given-names></name><name><surname>Takagaki</surname><given-names>Y</given-names></name><name><surname>Tonegawa</surname><given-names>S</given-names></name></person-group><article-title>Junctional sequences of T cell receptor gamma delta genes: implications for gamma delta T cell lineages and for a novel intermediate of V-(D)-J joining</article-title><source>Cell</source><year>1989</year><volume>59</volume><fpage>859</fpage><lpage>870</lpage><pub-id pub-id-type="pmid">2590942</pub-id></element-citation></ref><ref id="b143"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabelitz</surname><given-names>D</given-names></name><name><surname>Bender</surname><given-names>A</given-names></name><name><surname>Prospero</surname><given-names>T</given-names></name><name><surname>Wesselborg</surname><given-names>S</given-names></name><name><surname>Janssen</surname><given-names>O</given-names></name><name><surname>Pechhold</surname><given-names>K</given-names></name></person-group><article-title>The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells</article-title><source>J Exp Med</source><year>1991</year><volume>173</volume><fpage>1331</fpage><lpage>1338</lpage><pub-id pub-id-type="pmid">1827825</pub-id></element-citation></ref><ref id="b144"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Souza</surname><given-names>CD</given-names></name><name><surname>Cooper</surname><given-names>AM</given-names></name><name><surname>Frank</surname><given-names>AA</given-names></name><name><surname>Mazzaccaro</surname><given-names>RJ</given-names></name><name><surname>Bloom</surname><given-names>BR</given-names></name><name><surname>Orme</surname><given-names>IM</given-names></name></person-group><article-title>An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis</article-title><source>J Immunol</source><year>1997</year><volume>158</volume><fpage>1217</fpage><lpage>1221</lpage><pub-id pub-id-type="pmid">9013962</pub-id></element-citation></ref><ref id="b145"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vavassori</surname><given-names>S</given-names></name><etal/></person-group><article-title>Butyrophilin 3A1 binds phosphorylated antigens and stimulates human gammadelta T cells</article-title><source>Nat Immunol</source><year>2013</year><volume>14</volume><fpage>908</fpage><lpage>916</lpage><pub-id pub-id-type="pmid">23872678</pub-id></element-citation></ref><ref id="b146"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spencer</surname><given-names>CT</given-names></name><name><surname>Abate</surname><given-names>G</given-names></name><name><surname>Blazevic</surname><given-names>A</given-names></name><name><surname>Hoft</surname><given-names>DF</given-names></name></person-group><article-title>Only a subset of phosphoantigen-responsive gamma9delta2 T cells mediate protective tuberculosis immunity</article-title><source>J Immunol</source><year>2008</year><volume>181</volume><fpage>4471</fpage><lpage>4484</lpage><pub-id pub-id-type="pmid">18802050</pub-id></element-citation></ref><ref id="b147"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B</given-names></name><etal/></person-group><article-title>Disease-specific changes in gammadelta T cell repertoire and function in patients with pulmonary tuberculosis</article-title><source>J Immunol</source><year>1996</year><volume>157</volume><fpage>4222</fpage><lpage>4229</lpage><pub-id pub-id-type="pmid">8892660</pub-id></element-citation></ref><ref id="b148"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shen</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Adaptive immune response of Vgamma2Vdelta2+ T cells during mycobacterial infections</article-title><source>Science</source><year>2002</year><volume>295</volume><fpage>2255</fpage><lpage>2258</lpage><pub-id pub-id-type="pmid">11910108</pub-id></element-citation></ref><ref id="b149"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dieli</surname><given-names>F</given-names></name><etal/></person-group><article-title>Vgamma9/Vdelta2 T lymphocytes reduce the viability of intracellular Mycobacterium tuberculosis</article-title><source>Eur J Immunol</source><year>2000</year><volume>30</volume><fpage>1512</fpage><lpage>1519</lpage><pub-id pub-id-type="pmid">10820400</pub-id></element-citation></ref><ref id="b150"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Daker</surname><given-names>S</given-names></name><etal/></person-group><article-title>An abnormal phenotype of lung Vgamma9Vdelta2 T cells impairs their responsiveness in tuberculosis patients</article-title><source>Cell Immunol</source><year>2013</year><volume>282</volume><fpage>106</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">23770719</pub-id></element-citation></ref><ref id="b151"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinheiro</surname><given-names>MB</given-names></name><etal/></person-group><article-title>CD4-CD8-alphabeta and gammadelta T cells display inflammatory and regulatory potentials during human tuberculosis</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e50923</fpage><pub-id pub-id-type="pmid">23239994</pub-id></element-citation></ref><ref id="b152"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CY</given-names></name><etal/></person-group><article-title>Phosphoantigen/IL2 expansion and differentiation of Vgamma2Vdelta2 T cells increase resistance to tuberculosis in nonhuman primates</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003501</fpage><pub-id pub-id-type="pmid">23966854</pub-id></element-citation></ref><ref id="b153"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birkinshaw</surname><given-names>RW</given-names></name><name><surname>Kjer-Nielsen</surname><given-names>L</given-names></name><name><surname>Eckle</surname><given-names>SB</given-names></name><name><surname>McCluskey</surname><given-names>J</given-names></name><name><surname>Rossjohn</surname><given-names>J</given-names></name></person-group><article-title>MAITs, MR1 and vitamin B metabolites</article-title><source>Curr Opin Immunol</source><year>2014</year><volume>26</volume><fpage>7</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">24556396</pub-id></element-citation></ref><ref id="b154"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kjer-Nielsen</surname><given-names>L</given-names></name><etal/></person-group><article-title>MR1 presents microbial vitamin B metabolites to MAIT cells</article-title><source>Nature</source><year>2012</year><volume>491</volume><fpage>717</fpage><lpage>723</lpage><pub-id pub-id-type="pmid">23051753</pub-id></element-citation></ref><ref id="b155"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name><etal/></person-group><article-title>MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution</article-title><source>Proc Natl Acad Sci USA</source><year>2009</year><volume>106</volume><fpage>8290</fpage><lpage>8295</lpage><pub-id pub-id-type="pmid">19416870</pub-id></element-citation></ref><ref id="b156"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dusseaux</surname><given-names>M</given-names></name><etal/></person-group><article-title>Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells</article-title><source>Blood</source><year>2011</year><volume>117</volume><fpage>1250</fpage><lpage>1259</lpage><pub-id pub-id-type="pmid">21084709</pub-id></element-citation></ref><ref id="b157"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bourhis</surname><given-names>L</given-names></name><name><surname>Guerri</surname><given-names>L</given-names></name><name><surname>Dusseaux</surname><given-names>M</given-names></name><name><surname>Martin</surname><given-names>E</given-names></name><name><surname>Soudais</surname><given-names>C</given-names></name><name><surname>Lantz</surname><given-names>O</given-names></name></person-group><article-title>Mucosal-associated invariant T cells: unconventional development and function</article-title><source>Trends Immunol</source><year>2011</year><volume>32</volume><fpage>212</fpage><lpage>218</lpage><pub-id pub-id-type="pmid">21459674</pub-id></element-citation></ref><ref id="b158"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Bourhis</surname><given-names>L</given-names></name><etal/></person-group><article-title>MAIT cells detect and efficiently lyse bacterially-infected epithelial cells</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><fpage>e1003681</fpage><pub-id pub-id-type="pmid">24130485</pub-id></element-citation></ref><ref id="b159"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckle</surname><given-names>SB</given-names></name><etal/></person-group><article-title>A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells</article-title><source>J Exp Med</source><year>2014</year><volume>211</volume><fpage>1585</fpage><lpage>1600</lpage><pub-id pub-id-type="pmid">25049336</pub-id></element-citation></ref><ref id="b160"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MC</given-names></name><etal/></person-group><article-title>MR1-restricted MAIT cells display ligand discrimination and pathogen selectivity through distinct T cell receptor usage</article-title><source>J Exp Med</source><year>2014</year><volume>211</volume><fpage>1601</fpage><lpage>1610</lpage><pub-id pub-id-type="pmid">25049333</pub-id></element-citation></ref><ref id="b161"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gold</surname><given-names>MC</given-names></name><etal/></person-group><article-title>Human mucosal associated invariant T cells detect bacterially infected cells</article-title><source>PLoS Biol</source><year>2010</year><volume>8</volume><fpage>e1000407</fpage><pub-id pub-id-type="pmid">20613858</pub-id></element-citation></ref><ref id="b162"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harriff</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Human lung epithelial cells contain Mycobacterium tuberculosis in a late endosomal vacuole and are efficiently recognized by CD8(+) T cells</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><fpage>e97515</fpage><pub-id pub-id-type="pmid">24828674</pub-id></element-citation></ref><ref id="b163"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brigl</surname><given-names>M</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name></person-group><article-title>CD1: antigen presentation and T cell function</article-title><source>Annu Rev Immunol</source><year>2004</year><volume>22</volume><fpage>817</fpage><lpage>890</lpage><pub-id pub-id-type="pmid">15032598</pub-id></element-citation></ref><ref id="b164"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Montamat-Sicotte</surname><given-names>DJ</given-names></name><etal/></person-group><article-title>A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection</article-title><source>J Clin Invest</source><year>2011</year><volume>121</volume><fpage>2493</fpage><lpage>2503</lpage><pub-id pub-id-type="pmid">21576820</pub-id></element-citation></ref><ref id="b165"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torrelles</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Structural differences in lipomannans from pathogenic and nonpathogenic mycobacteria that impact CD1b-restricted T cell responses</article-title><source>J Biol Chem</source><year>2011</year><volume>286</volume><fpage>35438</fpage><lpage>35446</lpage><pub-id pub-id-type="pmid">21859718</pub-id></element-citation></ref><ref id="b166"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dascher</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Conservation of a CD1 multigene family in the guinea pig</article-title><source>J Immunol</source><year>1999</year><volume>163</volume><fpage>5478</fpage><lpage>5488</lpage><pub-id pub-id-type="pmid">10553074</pub-id></element-citation></ref><ref id="b167"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hiromatsu</surname><given-names>K</given-names></name><etal/></person-group><article-title>Characterization of guinea-pig group 1 CD1 proteins</article-title><source>Immunology</source><year>2002</year><volume>106</volume><fpage>159</fpage><lpage>172</lpage><pub-id pub-id-type="pmid">12047745</pub-id></element-citation></ref><ref id="b168"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dascher</surname><given-names>CC</given-names></name><etal/></person-group><article-title>Immunization with a mycobacterial lipid vaccine improves pulmonary pathology in the guinea pig model of tuberculosis</article-title><source>Int Immunol</source><year>2003</year><volume>15</volume><fpage>915</fpage><lpage>925</lpage><pub-id pub-id-type="pmid">12882829</pub-id></element-citation></ref><ref id="b169"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seshadri</surname><given-names>C</given-names></name><name><surname>Turner</surname><given-names>MT</given-names></name><name><surname>Lewinsohn</surname><given-names>DM</given-names></name><name><surname>Moody</surname><given-names>DB</given-names></name><name><surname>Van Rhijn</surname><given-names>I</given-names></name></person-group><article-title>Lipoproteins are major targets of the polyclonal human T cell response to Mycobacterium tuberculosis</article-title><source>J Immunol</source><year>2013</year><volume>190</volume><fpage>278</fpage><lpage>284</lpage><pub-id pub-id-type="pmid">23197260</pub-id></element-citation></ref><ref id="b170"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kasmar</surname><given-names>AG</given-names></name><etal/></person-group><article-title>CD1b tetramers bind alphabeta T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans</article-title><source>J Exp Med</source><year>2011</year><volume>208</volume><fpage>1741</fpage><lpage>1747</lpage><pub-id pub-id-type="pmid">21807869</pub-id></element-citation></ref><ref id="b171"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Rhijn</surname><given-names>I</given-names></name><etal/></person-group><article-title>A conserved human T cell population targets mycobacterial antigens presented by CD1b</article-title><source>Nat Immunol</source><year>2013</year><volume>14</volume><fpage>706</fpage><lpage>713</lpage><pub-id pub-id-type="pmid">23727893</pub-id></element-citation></ref><ref id="b172"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronenberg</surname><given-names>M</given-names></name><name><surname>Zajonc</surname><given-names>DM</given-names></name></person-group><article-title>A &#x02018;GEM&#x02019; of a cell</article-title><source>Nat Immunol</source><year>2013</year><volume>14</volume><fpage>694</fpage><lpage>695</lpage><pub-id pub-id-type="pmid">23778804</pub-id></element-citation></ref><ref id="b173"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Rhijn</surname><given-names>I</given-names></name><etal/></person-group><article-title>TCR bias and affinity define two compartments of the CD1b-glycolipid-specific T Cell repertoire</article-title><source>J Immunol</source><year>2014</year><volume>192</volume><fpage>4054</fpage><lpage>4060</lpage><pub-id pub-id-type="pmid">24683194</pub-id></element-citation></ref><ref id="b174"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kronenberg</surname><given-names>M</given-names></name><name><surname>Gapin</surname><given-names>L</given-names></name></person-group><article-title>The unconventional lifestyle of NKT cells</article-title><source>Nat Rev Immunol</source><year>2002</year><volume>2</volume><fpage>557</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">12154375</pub-id></element-citation></ref><ref id="b175"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tupin</surname><given-names>E</given-names></name><name><surname>Kinjo</surname><given-names>Y</given-names></name><name><surname>Kronenberg</surname><given-names>M</given-names></name></person-group><article-title>The unique role of natural killer T cells in the response to microorganisms</article-title><source>Nat Rev Microbiol</source><year>2007</year><volume>5</volume><fpage>405</fpage><lpage>417</lpage><pub-id pub-id-type="pmid">17487145</pub-id></element-citation></ref><ref id="b176"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sada-Ovalle</surname><given-names>I</given-names></name><name><surname>Chiba</surname><given-names>A</given-names></name><name><surname>Gonzales</surname><given-names>A</given-names></name><name><surname>Brenner</surname><given-names>MB</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Innate invariant NKT cells recognize Mycobacterium tuberculosis-infected macrophages, produce interferon-gamma, and kill intracellular bacteria</article-title><source>PLoS Pathog</source><year>2008</year><volume>4</volume><fpage>e1000239</fpage><pub-id pub-id-type="pmid">19079582</pub-id></element-citation></ref><ref id="b177"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothchild</surname><given-names>AC</given-names></name><name><surname>Jayaraman</surname><given-names>P</given-names></name><name><surname>Nunes-Alves</surname><given-names>C</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>iNKT cell production of GM-CSF controls Mycobacterium tuberculosis</article-title><source>PLoS Pathog</source><year>2014</year><volume>10</volume><fpage>e1003805</fpage><pub-id pub-id-type="pmid">24391492</pub-id></element-citation></ref><ref id="b178"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sada-Ovalle</surname><given-names>I</given-names></name><name><surname>Skold</surname><given-names>M</given-names></name><name><surname>Tian</surname><given-names>T</given-names></name><name><surname>Besra</surname><given-names>GS</given-names></name><name><surname>Behar</surname><given-names>SM</given-names></name></person-group><article-title>Alpha-galactosylceramide as a therapeutic agent for pulmonary Mycobacterium tuberculosis infection</article-title><source>Am J Respir Crit Care Med</source><year>2010</year><volume>182</volume><fpage>841</fpage><lpage>847</lpage><pub-id pub-id-type="pmid">20508216</pub-id></element-citation></ref><ref id="b179"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>K</given-names></name><etal/></person-group><article-title>KLRG+ invariant natural killer T cells are long-lived effectors</article-title><source>Proc Natl Acad Sci USA</source><year>2014</year><volume>111</volume><fpage>12474</fpage><lpage>12479</lpage><pub-id pub-id-type="pmid">25118276</pub-id></element-citation></ref><ref id="b180"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subbian</surname><given-names>S</given-names></name><etal/></person-group><article-title>Spontaneous latency in a rabbit model of pulmonary tuberculosis</article-title><source>Am J Pathol</source><year>2012</year><volume>181</volume><fpage>1711</fpage><lpage>1724</lpage><pub-id pub-id-type="pmid">22960076</pub-id></element-citation></ref><ref id="b181"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacchetti</surname><given-names>P</given-names></name><name><surname>Deeks</surname><given-names>SG</given-names></name><name><surname>McCune</surname><given-names>JM</given-names></name></person-group><article-title>Breaking free of sample size dogma to perform innovative translational research</article-title><source>Sci Transl Med</source><year>2011</year><volume>3</volume><fpage>87ps24</fpage></element-citation></ref><ref id="b182"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corey</surname><given-names>L</given-names></name><etal/></person-group><article-title>HIV-1 vaccines and adaptive trial designs</article-title><source>Sci Transl Med</source><year>2011</year><volume>3</volume><fpage>79ps13</fpage></element-citation></ref><ref id="b183"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Middelkoop</surname><given-names>K</given-names></name><etal/></person-group><article-title>Force of tuberculosis infection among adolescents in a high HIV and TB prevalence community: a cross-sectional observation study</article-title><source>BMC Infect Dis</source><year>2011</year><volume>11</volume><fpage>156</fpage><pub-id pub-id-type="pmid">21631918</pub-id></element-citation></ref><ref id="b184"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marx</surname><given-names>FM</given-names></name><etal/></person-group><article-title>The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study</article-title><source>Clin Infect Dis</source><year>2014</year><volume>58</volume><fpage>1676</fpage><lpage>1683</lpage><pub-id pub-id-type="pmid">24647020</pub-id></element-citation></ref><ref id="b185"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wood</surname><given-names>R</given-names></name><name><surname>Bekker</surname><given-names>LG</given-names></name></person-group><article-title>Isoniazid preventive therapy for tuberculosis in South Africa: an assessment of the local evidence base</article-title><source>S Afr Med J</source><year>2014</year><volume>104</volume><fpage>174</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">24897817</pub-id></element-citation></ref></